Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells

References

• Barth R F, Coderre J A, Vicente M G, Blue T E. Boron neutron capture therapy of cancer: Current status and future prospects. Clinical Cancer Research 2005; 11: 3987–4002
   PubMed Web of Science ®Google Scholar
• Boulares A H, Yakovlev A G, Ivanova V, Stoica B A, Wang G, Iyer S, Smulson M. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. The Journal of Biological Chemistry 1999; 274: 22932–22940
   PubMed Web of Science ®Google Scholar
• Castedo M, Perfettini J L, Roumier T, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, Vainchenker W, Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004; 23: 4362–4370
   PubMed Web of Science ®Google Scholar
• Chan T A, Hermeking H, Lengauer C, Kinzler K W, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616–620
   PubMed Web of Science ®Google Scholar
• Chang B D, Xuan Y, Broude E V, Zhu H, Schott B, Fang J, Roninson I B. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999; 18: 4808–4818
   PubMed Web of Science ®Google Scholar
• Coderre J A, Button T M, Micca P L, Fisher C D, Nawrocky M M, Liu H B. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. International Journal of Radiation Oncology, Biology and Physics 1994; 30: 643–652
   PubMed Web of Science ®Google Scholar
• Coderre J A, Morris G M. The radiation biology of boron neutron capture therapy. Radiation Research 1999; 151: 1–18
   PubMed Web of Science ®Google Scholar
• Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. International Journal of Oncology 2003; 22: 51–57
   PubMed Web of Science ®Google Scholar
• Dasika G K, Lin S C, Zhao S, Sung P, Tomkinson A, Lee E Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 1999; 18: 7883–7899
   PubMed Web of Science ®Google Scholar
• DeWeese T L, Shipman J M, Dillehay L E, Nelson W G. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. Journal of Urology 1998; 159: 591–598
   PubMed Web of Science ®Google Scholar
• Dimri G P, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E E, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 9363–9367
   PubMed Web of Science ®Google Scholar
• Dulic V, Kaufmann W K, Wilson S J, Tlsty T D, Lees E, Harper J W, Elledge S J, Reed S I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76: 1013–1023
   PubMed Web of Science ®Google Scholar
• Gallo O, Chiarelli I, Bianchi S, Calzolari A, Simonetti L, Porfirio B. Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer. Clinical Cancer Research 1996; 2: 1577–1582
   PubMedGoogle Scholar
• Harper J W, Adami G R, Wei N, Keyomarsi K, Elledge S J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• Hoffmann I, Clarke P R, Marcote M J, Karsenti E, Draetta G. Phosphorylation and activation of human cdc25-C by cdc2 – cyclin B and its involvement in the self-amplification of MPF at mitosis. The EMBO Journal 1993; 12: 53–63
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Hsieh L L, Wang P F, Chen I H, Wang H M, Chen M C, Chang J T, Cheng A J. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001; 22: 1497–1503
   PubMedGoogle Scholar
• Iwadate Y, Mizoe J, Osaka Y, Yamaura A, Tsujii H. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. International Journal of Radiation Oncology, Biology and Physics 2001; 50: 803–808
   PubMed Web of Science ®Google Scholar
• Jee Y H, Jeong W I, Kim T H, Hwang I S, Ahn M J, Joo H G, Hong S H, Jeong K S. p53 and cell-cycle-regulated protein expression in small intestinal cells after fast-neutron irradiation in mice. Molecular and Cellular Biochemistry 2005; 270: 21–28
   PubMedGoogle Scholar
• Kamida A, Obayashi S, Kato I, Ono K, Suzuki M, Nagata K, Sakurai Y, Yura Y. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. International Journal of Radiation Biology 2006; 82: 21–29
   PubMed Web of Science ®Google Scholar
• Kastan M B, Onyekwere O, Sidransky D, Vogelstein B, Craig R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991; 51: 6304–6311
   PubMed Web of Science ®Google Scholar
• Kastan M B, Zhan Q, el-Deiry W S, Carrier F, Jacks T, Walsh W V, Plunkett B S, Vogelstein B, Fornace A J, Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587–597
   PubMed Web of Science ®Google Scholar
• Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y. Effectiveness of BNCT for recurrent head and neck malignancies. Applied Radiation and Isotopes 2004; 2061: 1069–1073
   Web of Science ®Google Scholar
• Kuerbitz S J, Plunkett B S, Walsh W V, Kastan M B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 7491–7495
   PubMed Web of Science ®Google Scholar
• Leach S D, Scatena C D, Keefer C J, Goodman H A, Song S Y, Yang L, Pietenpol J A. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Research 1998; 58: 3231–3236
   PubMed Web of Science ®Google Scholar
• Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M, Beach D. mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 1991; 64: 1111–1122
   PubMed Web of Science ®Google Scholar
• Maggiorella L, Deutsch E, Frascogna V, Chavaudra N, Jeanson L, Milliat F, Eschwege F, Bourhis J. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo. Cancer Research 2003; 63: 2513–2517
   PubMed Web of Science ®Google Scholar
• Malashicheva A B, Kislyakova T V, Aksenov N D, Osipov K A, Pospelov V A. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Oncogene 2000; 19: 3858–3865
   PubMedGoogle Scholar
• Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Japanese Journal of Cancer Research 2002; 93: 1366–1377
   PubMedGoogle Scholar
• Matsui Y, Asano T, Kenmochi T, Iwakawa M, Imai T, Ochiai T. Effects of carbon-ion beams on human pancreatic cancer cell lines that differ in genetic status. American Journal of Clinical Oncology 2004; 27: 24–28
   PubMedGoogle Scholar
• Matsumura S, Matsumura T, Ozeki S, Fukushima S, Yamazaki H, Inoue T, Inoue T, Furusawa Y, Eguchi-Kasai K. Comparative analysis of G2 arrest after irradiation with 75 keV carbon-ion beams and 137Cs γ-rays in a human lymphoblastoid cell line. Cancer Detection and Prevention 2003; 27: 222–228
   PubMedGoogle Scholar
• Matsuoka S, Huang M, Elledge S J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998; 282: 1893–1897
   PubMed Web of Science ®Google Scholar
• McIlwrath A J, Vasey P A, Ross G M, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Research 1994; 54: 3718–3722
   PubMed Web of Science ®Google Scholar
• Millar J B, Russell P. The cdc25 M-phase inducer: An unconventional protein phosphatase. Cell 1992; 68: 407–410
   PubMed Web of Science ®Google Scholar
• Ng C E, Banerjee S K, Pavliv M, Wang G, Raaphorst G P, Aubin R A. p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines. International Journal of Radiation Biology 1999; 75: 1365–1376
   PubMedGoogle Scholar
• Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y. Delivery of 10boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Oral Oncology 2004; 40: 474–482
   PubMed Web of Science ®Google Scholar
• O'Connor P M, Ferris D K, Hoffmann I, Jackman J, Draetta G, Kohn K W. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 9480–9484
   PubMedGoogle Scholar
• Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyavsky M, Goldfinger N, Rotter V. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Research 2001; 61: 88–96
   PubMedGoogle Scholar
• Parker L L, Atherton-Fessler S, Lee M S, Ogg S, Falk J L, Swenson K I, Piwnica-Worms H. Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a wee1+ dependent manner. The EMBO Journal 1991; 10: 1255–1263
   PubMed Web of Science ®Google Scholar
• Peng C Y, Graves P R, Thoma R S, Wu Z, Shaw A S, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277: 1501–1505
   PubMed Web of Science ®Google Scholar
• Radford I R, Murphy T K. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. International Journal of Radiation Biology 1994; 65: 229–239
   PubMed Web of Science ®Google Scholar
• Roninson I B, Broude E V, Chang B D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resistance Updates 2001; 4: 303–313
   PubMed Web of Science ®Google Scholar
• Roninson I B. Tumor senescence as a determinant of drug response in vivo. Drug Resistance Updates 2002; 5: 204–208
   PubMed Web of Science ®Google Scholar
• Russell P, Nurse P. Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell 1987; 49: 559–567
   PubMed Web of Science ®Google Scholar
• Sanchez Y, Wong C, Thoma R S, Richman R, Wu Z, Piwnica-Worms H, Elledge S J. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277: 1497–1501
   PubMed Web of Science ®Google Scholar
• Stewart N, Hicks G G, Paraskevas F, Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995; 10: 109–115
   PubMed Web of Science ®Google Scholar
• Syljuasen R G, Sorensen C S, Nylandsted J, Lukas C, Lukas J, Bartek J. Inhibition of Chk1 by CEP-3891 accelerates mitotic nuclear fragmentation in response to ionizing Radiation. Cancer Research 2004; 64: 9035–9040
   PubMed Web of Science ®Google Scholar
• Takahashi A, Matsumoto H, Yuki K, Yasumoto J, Kajiwara A, Aoki M, Furusawa Y, Ohnishi K, Ohnishi T. High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. International Journal of Radiation Oncology, Biology and Physics 2004; 60: 591–597
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Chiba I, Hirai A, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Iizuka T, Kohgo T, Fukuda H. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation. American Journal of Clinical Oncology 2003; 26: e124–129
   PubMedGoogle Scholar
• Xiong Y, Hannon G J, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–704
   PubMed Web of Science ®Google Scholar